Latest SMS Lifesciences stock price

SMS Lifesciences P/E Ratio

SMSLIFE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.27
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 22.27
Current Price ₹1353.50
EPS (TTM) ₹66.51
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 9.08
Historical Range 6.93 - 12.65
Percentile 100.0%

Sector Context

Sector Average 53.64
Sector Median 31.12
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹58.57
Mar 2025 ₹9.83
Jun 2025 ₹13.75

Key P/E Ratio Insights for SMS Lifesciences

  • Current PE is 145.1% above historical average
  • Trading at discount to sector average PE of 53.64

View the SMSLIFE equity price for detailed stock performance.

P/E Ratio Historical Trend for SMS Lifesciences

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 6.93 76.22 ₹528.15 NSE Low
2022 12.65 58.23 ₹736.40 NSE Low
2021 8.79 70.33 ₹618.40 NSE Low
2020 7.97 33.29 ₹265.35 NSE Low

Sector P/E Ratio Comparison

Comparing SMS Lifesciences with other companies in Healthcare sector
Sector Average
53.64
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low